FDA leaders are moving to abandon a decades-old policy of asking outside experts to review drug applications, a move critics say would shield the agency's decisions from public scrutiny.
FDA leaders under President Trump are moving to abandon a decades-old policy of asking outside experts to review drug applications, a move critics say would shield the agency's decisions from public scrutiny. @arthurallen202.bsky.social has the details: kffhealthnews.org/news/article ...
-- KFF Health News (@kffhealthnews.org) Sep 12, 2025 at 11:22 AM
[image or embed]
Drudge Retort Headlines
Polls: Trump, GOP Taking More Blame for Shutdown (120 comments)
Obamacare Premiums Set to Skyrocket for Poorest Americans (45 comments)
Almost Half in New Poll Say Groceries Harder to Afford (39 comments)
U.S. Treasury May Put Trump on $1 Coin (33 comments)
White House in a Bind as Soybean Sales to China Plummet to Zero (24 comments)
Trump's Approval Rating Plunges With Low Income Voters (23 comments)
Repub Caught in Nazi Porn Scandal (22 comments)
Trump Turning to Socialism to Help US Farmers (20 comments)
ICE Dragged Unclothed Children Out of Homes in Chicago Raid (17 comments)
Trump Hit by Bad News as Latest Job Numbers Shock (17 comments)